Beyond shedding pounds, these medications positively impact numerous weight-related conditions: Cardiovascular disease risk reduction of approximately 20% (MACE) with GLP1s Improvements in sleep apnea (reduction of 6 fewer events per hour) Better management of non-alcoholic fatty liver disease Significant improvements in blood pressure, cholesterol, and blood sugar Reduced risk for cardiovascular and all-cause mortality Delayed progression to diabetes The weight loss threshold for meaningful health improvements typically starts at 5-10% of body weight
Mohanavelu, A., Naganna, S.R., and Al-Ansari, N., Irrigation induced salinity and sodicity hazards on soil and groundwater: An overview of its causes, impacts and mitigation strategies, Agriculture , 2021, vol
Many clinicians actively recommend PPI therapy for semaglutide users with significant reflux symptoms
Sierra, 65 The reduction in cravings and weight loss have come with ease
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update
Start Your New Year, New You Journey Today Choosing between tirzepatide vs semaglutide does not have to be overwhelming